Arterial embolism
Arterial embolism refers to a blood clot or foreign matter that enters a blood vessel and becomes an embolus. As blood flow stops in a peripheral artery or visceral artery of similar smaller caliber, it causes blood flow obstruction.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
More common in men over 45 years old -
Related symptoms:
Intermittent claudication lower back pain buttocks pain iliac fossa pain calf muscle pain and tenderness -
Concurrent disease:
Related Drugs
Urokinase for injection
Indication: The product is mainly used for thrombolytic therapy of thromboembolic diseases, including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Ma'anshan Fengyuan Pharmaceutical Co., Ltd.
Defibrase Injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA) and prevention of recurrent cerebral infarction. 2. Myocardial infarction, unstable angina and prevention of recurrent myocardial infarction. 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease. 4. Blood in a state of high viscosity, high coagulation, and pre-thrombotic state. 5. Sudden deafness. 6. Pulmonary embolism.
Manufacturer:
Beijing Science Sun Pharmaceutical Co., Ltd.
Defibrase for injection
Indication: (1) Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrent cerebral infarction. (2) Myocardial infarction, unstable angina pectoris, and prevention of recurrent myocardial infarction. (3) Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease. (4) Blood in a hyperviscosity state, hypercoagulable state, and prethrombotic state. (5) Sudden deafness. (6) Pulmonary embolism.
Manufacturer:
Beijing Science Sun Pharmaceutical Co., Ltd.
Defibrase for injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrent cerebral infarction. 2. Myocardial infarction, unstable angina pectoris, and prevention of recurrent myocardial infarction. 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease. 4. Blood in a state of high viscosity, high coagulation, and prethrombotic state. 5. Sudden deafness. 6. Pulmonary embolism.
Manufacturer:
Henan Tianzhi Pharmaceutical Co., Ltd.
Defibrase for injection
Indication: (1) Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrent cerebral infarction. (2) Myocardial infarction, unstable angina pectoris, and prevention of recurrent myocardial infarction. (3) Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease. (4) Blood in a hyperviscosity state, hypercoagulable state, and prethrombotic state. (5) Sudden deafness. (6) Pulmonary embolism.
Pentoxifylline Sodium Chloride Injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia. 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal artery occlusion, intermittent claudication or rest pain. 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness. Ocular circulation disorders such as diabetic retinal artery embolism.
Manufacturer:
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Pentoxifylline Sodium Chloride Injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal artery occlusion, intermittent claudication or rest pain; 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; 4. Ocular circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:
Henan Shuanghe Huali Pharmaceutical Co., Ltd.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:
Jiangsu Dahongying Hengshun Pharmaceutical Co., Ltd.
Related Ingredients